Cloverleaf Bio, Inc.

New Filing
CIK: 0002153574·Biotechnology·DELAWARE·Filed: Sep 8, 2026
Total Offering

$29,599,977

Amount Sold

$14,799,988

Investors

12

First Sale

Aug 24, 2026

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2023
Non-Accredited Investors
No

Related Persons

NameRole
Austin Draycott
Cole Lewis
Dima Kuzmin
Christina Vorvis
Matthias Samwer

Company

Cloverleaf Bio, Inc.

101 COLLEGE STREET, #210

NEW HAVEN, CT, 06510

347-596-9754

SEC Filing

0002153574-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free